MX2019012380A - Cristales de compuesto piranodipiridinico. - Google Patents
Cristales de compuesto piranodipiridinico.Info
- Publication number
- MX2019012380A MX2019012380A MX2019012380A MX2019012380A MX2019012380A MX 2019012380 A MX2019012380 A MX 2019012380A MX 2019012380 A MX2019012380 A MX 2019012380A MX 2019012380 A MX2019012380 A MX 2019012380A MX 2019012380 A MX2019012380 A MX 2019012380A
- Authority
- MX
- Mexico
- Prior art keywords
- crystals
- compound
- pyranodipyridine
- pyranodipyridine compound
- available
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000013078 crystal Substances 0.000 title abstract 2
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente invención proporciona un cristal del compuesto representado por la fórmula (I) que tiene aplicación como sustancia farmacológica de productos farmacéuticos. (ver Fórmula).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017093147 | 2017-05-09 | ||
| PCT/JP2018/017577 WO2018207715A1 (ja) | 2017-05-09 | 2018-05-07 | ピラノジピリジン化合物の結晶 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019012380A true MX2019012380A (es) | 2020-01-23 |
Family
ID=64105205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019012380A MX2019012380A (es) | 2017-05-09 | 2018-05-07 | Cristales de compuesto piranodipiridinico. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210323972A1 (es) |
| EP (1) | EP3623373A1 (es) |
| JP (1) | JPWO2018207715A1 (es) |
| KR (1) | KR20200004792A (es) |
| CN (1) | CN110520426A (es) |
| AU (1) | AU2018267362A1 (es) |
| BR (1) | BR112019021933A2 (es) |
| CA (1) | CA3059683A1 (es) |
| MX (1) | MX2019012380A (es) |
| RU (1) | RU2019132968A (es) |
| SG (1) | SG11201909483WA (es) |
| WO (1) | WO2018207715A1 (es) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4018777A (en) * | 1975-11-14 | 1977-04-19 | Abbott Laboratories | 2-Substituted-5-alkyl resorcinols |
| DE19532050A1 (de) * | 1995-08-31 | 1997-03-06 | Basf Ag | Pyrrolyl-tetrahydrochinoxalindione, ihre Herstellung und Verwendung zur Bekämpfung von Krankheiten |
| IL154709A0 (en) | 2000-09-18 | 2003-10-31 | Eisai Co Ltd | Pyridazinone and triazinone derivatives and pharmaceutical compositions containing the same |
| US20100256191A1 (en) * | 2007-12-26 | 2010-10-07 | Eisai R&D Management Co., Ltd. | Ampa receptor antagonists and zonisamide for epilepsy |
| AU2016351424B2 (en) * | 2015-11-13 | 2020-06-25 | Eisai R&D Management Co., Ltd. | Pyranodipyridine compound |
-
2018
- 2018-05-07 JP JP2019517601A patent/JPWO2018207715A1/ja active Pending
- 2018-05-07 CA CA3059683A patent/CA3059683A1/en not_active Abandoned
- 2018-05-07 MX MX2019012380A patent/MX2019012380A/es unknown
- 2018-05-07 BR BR112019021933A patent/BR112019021933A2/pt not_active Application Discontinuation
- 2018-05-07 US US16/605,424 patent/US20210323972A1/en not_active Abandoned
- 2018-05-07 AU AU2018267362A patent/AU2018267362A1/en not_active Abandoned
- 2018-05-07 KR KR1020197030222A patent/KR20200004792A/ko not_active Withdrawn
- 2018-05-07 SG SG11201909483W patent/SG11201909483WA/en unknown
- 2018-05-07 RU RU2019132968A patent/RU2019132968A/ru not_active Application Discontinuation
- 2018-05-07 CN CN201880024413.XA patent/CN110520426A/zh active Pending
- 2018-05-07 EP EP18797555.2A patent/EP3623373A1/en not_active Withdrawn
- 2018-05-07 WO PCT/JP2018/017577 patent/WO2018207715A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN110520426A (zh) | 2019-11-29 |
| JPWO2018207715A1 (ja) | 2020-03-12 |
| RU2019132968A (ru) | 2021-06-09 |
| KR20200004792A (ko) | 2020-01-14 |
| EP3623373A1 (en) | 2020-03-18 |
| AU2018267362A1 (en) | 2019-10-31 |
| US20210323972A1 (en) | 2021-10-21 |
| CA3059683A1 (en) | 2018-11-15 |
| SG11201909483WA (en) | 2019-11-28 |
| WO2018207715A1 (ja) | 2018-11-15 |
| BR112019021933A2 (pt) | 2020-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4071149A3 (en) | Heterocyclic compounds and uses thereof | |
| TW201613911A (en) | Heterocyclic compounds and uses thereof | |
| PH12018501099A1 (en) | Novel biphenyl compound or salt thereof | |
| TN2018000239A1 (en) | New ammonium derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| SA520411524B1 (ar) | مركبات تنشيط القسيم العضلي ثنائي الأميد واستخداماتها | |
| PH12015501996B1 (en) | Heterocyclic compounds and uses thereof | |
| TN2017000529A1 (en) | New hydroxyacid derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| MY196909A (en) | Boronic acid derivatives and therapeutic uses thereof | |
| MX2020005944A (es) | Analogos espirobiciclicos novedosos. | |
| PH12019500731A1 (en) | Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors | |
| CA2891755C (en) | Substituted pyrido-piperazinone derivatives as gamma secretase modulators | |
| MX2017001624A (es) | Sal de derivado de piridina monociclico y su cristal. | |
| PH12020550133A1 (en) | Crystal forms of immunomodulators | |
| EP3613419A4 (en) | PHARMACEUTICAL COMPOSITION WITH INDIRUBY DERIVATIVE AS THE ACTIVE SUBSTANCE | |
| MX2016013431A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| MX2016014946A (es) | Derivados de carboxamida. | |
| MX2017008074A (es) | DERIVADOS DE IMIDAZOPIRIDAZINA COMO INHIBIDORES DE FOSFOINOSITIDA-3-QUINASAS BETA (PI3Kß). | |
| MX2017008076A (es) | DERIVADOS DE IMIDAZOPIRIDAZINA ENLAZADOS A HETEROCICLILO COMO INHIBIDORES DE PI3Kß. | |
| IN2014MU00859A (es) | ||
| MX2019012380A (es) | Cristales de compuesto piranodipiridinico. | |
| MX2021009774A (es) | Sal de un compuesto pentaciclico y su cristal. | |
| MX2016013428A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| MX2016005539A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| MX2018010652A (es) | Composiciones farmaceuticas. | |
| MX2017010992A (es) | Composiciones farmaceuticas estables que comprenden agente antibacteriano. |